Plerixafor Plus Donor Lymphocyte Infusion for Relapsed Acute Leukemia After Allo-HSCT
Clinical trial NCT06141304 · UNKNOWN
Trial details
- NCT number
- NCT06141304
- Sponsor
- The First Hospital of Jilin University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-01
- Primary completion
- 2025-01-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.